Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Stroke


Phase 1 Results N/A

Summary of Purpose

Stroke is one of the leading causes of disability in the world, and stem cell - transplantation provides a promising approach for rehabilitation. The main objective of this study is to evaluate the efficacy of the intracerebral injection of autologous bone marrow mesenchymal stem cells in patients with chronic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 June 2015.

1 Jun 2012 19 Oct 2012 1 Oct 2015 1 Dec 2015 1 Jun 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


  • Qichuan Zhuge, M.D.